Neurotez, Inc. to Present at the 2008 Mid-Atlantic Capital (MAC) Conference
12/1/2008 10:50:35 AM
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Neurotez, Inc., a company developing therapies for Alzheimer’s disease, today announced that it has been selected as a Featured Company for the 2008 MAC Conference. A Presentation will be held on Wednesday, December 3 by Chief Executive Officer, Dr. Nikolaos Tezapsidis on 2:45pm in Life Sciences Room 201ABC at the Pennsylvania Convention Center, Philadelphia, PA.
comments powered by